Low-Cost, Web-Based Cardiac Nuclear Study Viewer Launched

 
June 4, 2010

June 4, 2010 – A monthly, online service was launched today that allows clinicians to review and interpret general and cardiac nuclear medicine studies from anywhere in the world for a low monthly rate. The Medx Web Viewer permits interpretation of any original equipment manufacturer (OEM) dataset with nuclear medicine-specific color tables and cine movie displays.

The viewer was tailored specifically for nuclear medicine and was designed to aid workflow, compatibility, functionality and security.

Demonstrations of the Medx Web Viewer will be available at the Society of Nuclear Medicine (SNM) meeting, booth 739, in Salt Lake City this weekend. Medx is also offering free, 45-day trials of the Web-based interpretation service during SNM.

For more Information: www.medx-inc.com

More like this

The content of this field is kept private and will not be shown publicly.
By submitting this form, you accept the Mollom privacy policy.

Related News

Positron Introduces Next Generation PosiRx Pharmacy Automation Systems

May 16, 2013 — Positron Corp. announced the release of the PosiRx 3000-Series, its latest pharmacy automation systems. The PosiRx 3000-Series are the first systems to automate and encompass the...

Cardiac Imaging Agent Helps Make the World Safer From Nuclear Weapons

As the U.S. government works to strengthen its global nuclear security strategy by eliminating potential sources of bomb-grade highly enriched uranium (HEU), it has eyed the production of medical...

Bayer Enters Agreement to Expand Markets for Medrad Intego PET Infusion System

March 5, 2013 - Bayer Healthcare is expanding its global distribution network for the Medrad Intego positron emission tomography (PET) Infusion System through a new distribution agreement with...

View all

Related Articles

Cardiac Imaging Agent Helps Make the World Safer From Nuclear Weapons

As the U.S. government works to strengthen its global nuclear security strategy by eliminating potential sources of bomb-grade highly enriched uranium (HEU), it has eyed the production of medical...

FDA: Stop Using CardioGen-82 Due to Increased Radiation Exposure

July 26, 2011 – The U.S. Food and Drug Administration (FDA) is alerting healthcare professionals to stop using CardioGen-82 for cardiac positron emission tomography (PET) scans....

Time for a New Normal in Nuclear Cardiology?

As production of molybdenum-99 returns to normal with the Canadian Chalk River Laboratories reactor back online and the supply of 99m-technetium stabilizes, the nuclear cardiology community is...

View all